11/14
08:12 am
biaf
bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 [Yahoo! Finance]
Low
Report
bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024 [Yahoo! Finance]
11/14
08:00 am
biaf
bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
Medium
Report
bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024
11/4
08:00 am
biaf
bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
Low
Report
bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development
10/30
11:19 am
biaf
U.S. Testing Laboratories, Safety and Compliance Services Industry Report 2024: Market Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030 [Yahoo! Finance]
Low
Report
U.S. Testing Laboratories, Safety and Compliance Services Industry Report 2024: Market Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030 [Yahoo! Finance]
10/30
08:00 am
biaf
bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung
Medium
Report
bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung
10/21
11:39 am
biaf
WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement
Medium
Report
WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement
10/21
10:45 am
biaf
bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement
Medium
Report
bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement
10/18
02:57 pm
biaf
WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement
Medium
Report
WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement
10/18
12:45 pm
biaf
bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement
High
Report
bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement
10/16
08:00 am
biaf
bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines
High
Report
bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines
10/10
08:00 am
biaf
bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer
Medium
Report
bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer
10/9
08:00 am
biaf
bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test
Medium
Report
bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test
9/18
08:00 am
biaf
Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis
Medium
Report
Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis
8/23
05:21 pm
biaf
bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO [Yahoo! Finance]
Low
Report
bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO [Yahoo! Finance]
8/23
05:15 pm
biaf
bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO
Medium
Report
bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO